Goldman Sachs analyst Michael Peet removed Elders from the firm’s Conviction List but keeps a Buy rating on the shares with a A$13.20 price target. The analyst believes the stock’s current valuation has more than factored in any cyclical earnings impact and "significantly undervalues the quality of the company."
Published first on TheFly
